Macquarie analysts say the Reserve Bank of Australia will keep the cash rate unchanged at next week’s meeting but will deliver a hawkish signal to reinforce market bets on an August rate hike. Recent RBA communications show no sign of contemplating rate cuts. Macquarie’s AI analysis of official wording under the past three governors finds the current tone closely mirrors prior pre-hike periods. Analysts judge the RBA intends to keep the prospect that "further rate hikes remain on the table" unti

2026-06-09

Macquarie analysts say the Reserve Bank of Australia will keep the cash rate unchanged at next week’s meeting but will deliver a hawkish signal to reinforce market bets on an August rate hike. Recent RBA communications show no sign of contemplating rate cuts. Macquarie’s AI analysis of official wording under the past three governors finds the current tone closely mirrors prior pre-hike periods. Analysts judge the RBA intends to keep the prospect that "further rate hikes remain on the table" until inflation risks are resolved.

其他消息
2026-06-09

UK foreign secretary says it is necessary to keep the Strait of Hormuz open to restore regional stability.

2026-06-09

个股新闻 1. 康特隆(01912.HK)控股权将易主,获折让约34.82%提全购要约,6月9日复牌。 2. SENASIC(06675.HK)于6月9日至6月12日招股,拟全球发售5340.7万股H股。 3. 石药集团(01093.HK):司美格鲁肽长效注射液(SYH 9017) 在美国获临床试验批准。 4. 兆科眼科(06622.HK):董事会已批准一项为期十二个月的股份购回计划,总购回金额不超过1亿港元。 5. 越秀地产(00123.HK):5月本公司实现合同销售(连同合营企业及联营公司项目的合同销售)金额约为人民币113.03亿元,同比上升约18.0%,实现合同销售面积约为32.52万平方米,同比上升约33.0%。 6. 腾讯控股(00700.HK):6月8日于港交所斥资约5亿港元回购111.6万股。 7. 荣昌生物(09995.HK):国家药监局附条件批准泰它西普注射液(RC18)用于治疗IgA肾病的新适应症的上市申请。